Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | ABBV | REGN |
|---|
| Close | 294.89 | 927.89 |
| Market Cap | $522B | $93.4B |
| 1M | +12.73% | +22.37% |
| P/E (TTM) | 81.4 | 19.5 |
| Forward P/E | 16.9 | 13.4 |
| P/E 5-Yr Percentile | 62 | 56 |
| P/S | 8.0 | 5.4 |
| P/B | — | 2.7 |
| Dividend Yield | 4.47% | 0.45% |
| Latest Quarter Revenue | $17.0B | $5.1B |
| Revenue YoY | +10.2% | +36.3% |
| Gross Margin | 74.7% | — |
| Latest Quarter EPS | 2.03 | 18.45 |
| Avg Post-Earnings Move | ±1.7% | ±1.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 3.66% |
| 90-Day Net Insider Buying | −$8.2M | −$6.5M |
ABBV · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
